Overview
The fund is managed with an indexed method and is distinguished by broad diversification, low tracking errors, and low-cost management.
The investment objective is to replicate the reference index as closely as possible and to minimize performance deviations from the benchmark.
The MSCI Switzerland Index is designed to measure the performance of the large and mid cap segments of the Swiss market.
The index covers approximately 85% of the free float-adjusted market capitalization in the Swiss equity universe.
The fund is passively managed.
Benefits
Easy access to a broadly diversified portfolio of Swiss Equities.
Provides access to the performance of the index with a single transaction.
The fund is transparent and cost-effective and is liquid under normal market conditions.
You do not pay any federal stamp duty.
Risks
Features
| Product category |
Equity Switzerland |
| Product domicile |
Switzerland
|
| Portfolio management |
麻豆社 Asset Management Switzerland AG, Zurich
|
| Fund management |
麻豆社 Fund Management (Switzerland) AG
|
| Custodian bank |
麻豆社 Switzerland AG, Zurich
|
| Day of inception |
January 30, 2018
|
| Currency of account |
CHF
|
| Close of financial year |
February 28
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.05% p.a.
|
| Flat fee |
0.04% p.a.
|
| Management fee |
0.04% p.a.
|
| Total expense ratio (TER) |
0.08% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark | |
| Cut-Off Time |
14:00h(CET)
|
| Securities no. |
23338821
|
| ISIN |
CH0233388211
|
| Bloomberg Ticker |
CSSWBDA SW
|
| Reuters Id |
23338821X.CHE
|
Performance and Prices
Percentage growth
as of March 3, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 0.99 | 3.45 | 1.95 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 17.77 | 18.78 | 34.72 |
| 3Y | |||
| 5Y | 38.98 | 69.47 | 62.44 |
| ø p.a.5Y | 6.80 | 11.13 | 10.19 |
Current data
| Net asset value | 05.03.2026 | CHF 0.00 |
| High - last 12 months | 27.02.2026 | CHF 1,710.03 |
| Low - last 12 months | 05.03.2026 | CHF 0.00 |
| Total product assets in mn | 04.03.2026 | CHF 0.33 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 28.02.2026 | 10.58% | 12.19% |
| Sharpe Ratio | 28.02.2026 | 1.26 | 0.64 |
| Risk Free Rate | 28.02.2026 | 0.54% | 0.39% |
Structures
By the 10 largest positions (in %, as of January 30, 2026)
|
|
|
| Roche Holding AG | 16.56 |
| Novartis AG | 14.00 |
| Nestle SA | 12.15 |
| 麻豆社 Group AG | 7.42 |
| ABB Ltd | 6.71 |
| Cie Financiere Richemont SA | 5.17 |
| Zurich Insurance Group AG | 5.16 |
| Holcim AG | 2.61 |
| Swiss Re AG | 2.37 |
| Others | 27.86 |
By sector (in %, as of January 30, 2026)
|
|
|
| Pharma & Biotech | 36.00 |
| Food & soft drinks | 12.15 |
| Capital goods | 10.61 |
| Insurances | 10.09 |
| Diversified Financials | 9.81 |
| Materials | 6.10 |
| Consumer Durables & Apparel | 5.51 |
| Health Care | 2.70 |
| Food, Beverage & Tobacco | 1.77 |
| Others | 5.27 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|